يعرض 301 - 320 نتائج من 14,607 نتيجة بحث عن '(( significantly increased decrease ) OR ( significant ((anti decrease) OR (mean decrease)) ))', وقت الاستعلام: 0.48s تنقيح النتائج
  1. 301
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …"
  7. 307

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …"
  8. 308

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Background<p>Umbilical cord blood (UCB)-derived CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low</sup> regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …"
  9. 309

    Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf حسب Yi Li (1144)

    منشور في 2025
    "…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…"
  10. 310

    Fig 1 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  11. 311

    Fig 5 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  12. 312
  13. 313
  14. 314
  15. 315

    Fig 10 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  16. 316
  17. 317

    Fig 4 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  18. 318

    Fig 9 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  19. 319

    Fig 6 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  20. 320

    Fig 7 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات: